Cancer Diagnostics and Risk Assessment

Technology Transfer Contacts

(technologies available for licensing)
Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11
 
 
TECH ID TITLE LEAD INVENTOR CONTACT

 07-43

Biomarkers for Early Pancreatic Cancer Detection and Treatment

Patent No. US8609437B2; Summary

  Anthony Yeung 

Inna Khartchenko

 256-JT

Novel Diagnostic and Prognostic Marker for Malignant Mesothelioma 

Patent No. US10344333B2Summary

 Joseph Testa

Tatiana Venkova

 305-MC

Estrogen Metabolite Levels and CYP1B1 Polymorphisms in Lung Cancer Diagnosis, Prognosis, and Risk Assessment

Published Application No.US20190180877A1

 Margie Clapper

Natalia Shalginskikh

 312-GE

Novel Diagnostic Method for Predisposition to Colorectal Cancer

Patent No. US9157124B2; Summary

 Greg Enders

Tatiana Venkova

 394-EG

Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer

Published Application No.WO2017049023A1; Summary

Patent No. US10724100B2

Other Patent Applications Pending

Erica Golemis

Tatiana Venkova

 396-EC

Novel Biomarker For Risk Assessment And Treatment Evaluation For Cancers With Fibrosis

Published Application No.WO2018005355; Summary

Edna Cukierman 

Natalia Shalginskikh

 426-SA

Methods For Diagnosis And Treatment Of Patients Having Solid Tumors

Published Application No.US20200232041A1; Summary

Sanjeevani Arora

Tatiana Venkova

431-WE

High EGFR Somatic Mutation Frequency Targeting the TK Domain in Colorectal Cancer Patients with Microsatellite Instability (MSI)

Published Application No.WO2018157032A1Summary

Wafik El-Deiry

Tatiana Venkova

 443-JFB

Novel Cancer Prognostic based on MHC-I Genotype and Presentability

Published Application No.WO2019005764A1; Summary

Joan Font-Burgada

Tatiana Venkova

461-PA

 Urinary DNA Detection for Monitoring of Urothelial Cancer

Published Application No.WO2019222325A1;  Summary

Philip Abbosh

Natalia Shalginskikh

516-ZY

Applications of exosomes in the diagnosis of brain tumors

Published Application No.WO2021216733A2

Zeng-Jie Yang

Natalia Shalginskikh

522-MC

Estrogen Metabolite Levels and EGFR Mutations in Lung Cancer Risk Stratification and Treatment

Published Application No.WO2021142408A1

Margie Clapper

Natalia Shalginskikh

534-JR

The usage of r-HCG and the genomic signature of the breast induced by r-HCG in BRCA 1/2 carriers

Published Application No.WO2022125417A1Summary

Jose Russo

Natalia Shalginskikh

546-JT

Malignant Mesothelioma Susceptibility as a Result of Germline Gene Alteration: novel prognostic and diagnostic marker for mesothelioma.

Patent pending; Summary

Joseph Testa

Tatiana Venkova